Ισραήλ - Εβραϊκά - Ministry of Health

novartis israel ltd - betamethasone as dipropionate; calcipotriol as monohydrate - משחה - betamethasone as dipropionate 0.50 mg/g; calcipotriol as monohydrate 0.050 mg/g - betamethasone

Ισραήλ - Εβραϊκά - Ministry of Health

novartis israel ltd - etanercept - תמיסה להזרקה - etanercept 25 mg / 0.5 ml - etanercept

Ισραήλ - Εβραϊκά - Ministry of Health

novartis israel ltd - etanercept - תמיסה להזרקה - etanercept 50 mg / 1 ml - etanercept

Ισραήλ - Εβραϊκά - Ministry of Health

pharma shalom - ciclopirox - לק - ciclopirox 80 mg/g - ciclopirox - ciclopirox - for the treatment of fungal infections of the nails.

Ισραήλ - Εβραϊκά - Ministry of Health

sanofi israel ltd - insulin glulisine - תמיסה להזרקה - insulin glulisine 100 u/ml - insulin glulisine - insulin glulisine - treatment of adults, adolescents and children, 6 years or older with diabetes mellitus, where treatment with insulin is required.

Ισραήλ - Εβραϊκά - Ministry of Health

sanofi - aventis israel ltd - ofloxacin 2 mg/ml - solution for infusion - ofloxacin - infections of kidney, urinarty tract, genital organs, respiratory tract, chronic and recurrent ear, nose and throat, skin and soft tissues, bones and joints, bacterial enteritis, abdominal cavity, including pelvis minor and septicemia caused by ofloxacin sensitive microorganisms. prevention of infections in patients with a signifcant reduction of resistance to infections,

Ισραήλ - Εβραϊκά - Ministry of Health

sanofi - aventis israel ltd - levofloxacin as hemihydrate - תמיסה לאינפוזיה - levofloxacin as hemihydrate 5 mg/ml - levofloxacin - levofloxacin - in adults for whom intravenous therapy is considered to be appropriate, tavanic solution for infusion is indicated for the treatment of the following infections when due to levofloxacin - susceptible micro-organisms: community- acquired pneumonia, complicated urinary tract infections including pyelonephritis, skin and soft tissue infections.

Ισραήλ - Εβραϊκά - Ministry of Health

sanofi - aventis israel ltd - docetaxel as trihydrate 20 mg / 1 ml - concentrate for solution for infusion - docetaxel - breast cancer: taxotere (docetaxel) in combination with doxorubicin and cyclophosphamide is indicated for the adjuvant treatment of patients with operable node- positive breast cancer. taxotere (docetaxel) in combination with doxorubicin is indicated for the treatment of patients with locally advanced or metastatic breast cancer who have not previously received cytotoxic therapy for this condition. taxotere(docetaxel) monotherapy is indicated for the treatment of patients with metastatic breast cancer after failure of cytotoxic therapy. previous chemotherapy should have included an anthracycline or an alkylating agent. taxotere (docetaxel) in combination with trastuzumab is indicated for the treatment of patients with metastatic breast cancer whose tumors overexpress her2 and who previously have not received chemotherapy for metastatic disease. taxotere (docetaxel) in combination with capecitabine is indicated for the treatment of patients with metastatic breast cancer after failure of cytotoxic chemotherapy.

Ισραήλ - Εβραϊκά - Ministry of Health

sanofi - aventis israel ltd - cabazitaxel 60 mg / 1.5 ml - concentrate for solution for infusion - cabazitaxel - in combination with prednisone for the treatment of patients with metastatic hormone refractory prostate cancer (mhrpc) previously treated with a docetaxel-based treatment regimen

Ισραήλ - Εβραϊκά - Ministry of Health

sanofi israel ltd - cabazitaxel - תרכיז וממס להכנת תמיסה לאינפוזיה - cabazitaxel 60 mg / 1.5 ml - cabazitaxel - cabazitaxel - in combination with prednisone for the treatment of patients with metastatic hormone refractory prostate cancer (mhrpc) previously treated with a docetaxel-based treatment regimen